Pfizer Inc PFE

Buzz on the Bullboards: Major developments amidst market dynamics

[Jonathon Brown]

Several TSX-listed companies are making headlines with significant updates, strategic movements and quarterly reports. read article.

[PressRelease]

– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), and safety profile of vepdegestrant in combination with palbociclib were consistent with data previously reported at SABCS in December 2023 – ...read article.

[ecolo101]

Good increase today on small trading volume. This is positive for Pfizer. just think if we would have a strong trading volume with people holding to their shares, this would give powerful momentum to

[ecolo101]

Do not sell your shares. Until we turn around the retail which is still selling low,  but don't sell. institutions will come back as they need to buy low and have their fund and portfolio to

[PressRelease]

16 abstracts feature new data and post-hoc analyses of pivotal trials across several types of hard-to-treat cancers TOKYO, May 13, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new research from across its innovative portfolio of...read article.

[ecolo101]

Difficult to understand following good quarterly results. good And safe dividend and interest cut coming later in September. on closing we secure the dividend at $0.42 per share. So 1.5% for the

[ecolo101]

Yesterday and today on opening or closure..... whith a strong Q1 reports how can we see these tentatives to squeeze it down when revenues are proven and there. this type of market around any stock

[ecolo101]

$.42 per share....wow.  this stock should be above $30 but just my view. dyodd glta

[ecolo101]

Ouch not good. Although ex dividend is later this week no need to loose it before the cutoff date.... pfizer has no strength at the moment. Have we touched the bottom?  Hopefully yes. glta

[PressRelease]

Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla. He joins...read article.

[ecolo101]

Here are the stats. We are slowly but surely walking toward the 200 MDA.  Period Moving Average Price Change 20-Day 26.10 +0.43

[ecolo101]

PFE  Pfizer Inc.  Q1  $0.82  Beat by $0.31 PFE  Pfizer Inc.  Q1 

[ecolo101]

We are way higher than the average 42 millions shares per day we are at 55 million and keep increasing. this is very good with a 6% stock price increase. we have the real W shape and it is going up

[ecolo101]

And here we go, up up and probably up...  and ex dividend date coming soon. glta dyodd

[PressRelease]

Solid First-Quarter Results Reflect Continued Growth of Key Products and Progress in Executing 2024 Priorities First-Quarter 2024 Revenues of $14.9 Billion Expected Decline in Comirnaty(1) and Paxlovid Revenues Drove a Year-Over-Year Operational Decrease in Revenues of 19% Excluding...read article.

[ecolo101]

Difficult to understand and on top maximum inflation lately. So if you put it in constant dollar, this is a disaster. Bagholders are suffering and they need a vaccine... what will trigger a small leg